Related Experiment Video
Updated: Sep 3, 2025

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light
Hannah Kunstek1,2, Fanny Vreken1, Aminata Keita1,3
1L2CM, Université de Lorraine, Centre National de la Recherche Scientifique (CNRS), 54000 Nancy, France.
Abstract:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which caused the COVID-19 pandemic spreading around the world from late 2019, served as a ruthless reminder of the threat viruses pose to global public health. The synthesis of new antiviral drugs, as well as repurposing existing products, is a long-term ongoing process which has challenged the scientific community. One solution could be an effective, accessible, and rapidly available antiviral treatment based on phototherapy (PT). PT has been used to treat several diseases, and relies on the absorption of light by endogenous molecules or exogenous photosensitizers (PS). PT has often been used in cancer treatment and prophylaxis, and as a complement to established chemotherapy and immunotherapy in combined therapeutic strategy. Besides significant applications in anticancer treatment, studies have demonstrated the beneficial impact of PT on respiratory, systemic, emerging, and oncogenic viral infections. The aim of this review was to highlight the potential of PT to combat viral infections by summarizing current progress in photodynamic, photothermal, and photoacoustic approaches. Attention is drawn to the virucidal effect of PT on systemic viruses such as the human immunodeficiency virus and human herpes viruses, including the causative agent of Kaposi sarcoma, human herpes virus (HHV8). PT has good potential for disinfection in anti-norovirus research and against pandemic viruses like SARS-CoV-2.
Insights
Phototherapy (PT) offers a promising antiviral strategy by using light absorption to combat viral infections. This approach shows potential against various viruses, including SARS-CoV-2, offering an accessible treatment option.
Area of Science:
- Photomedicine
- Virology
- Biophysics
Background:
- Emerging viral threats like SARS-CoV-2 underscore the need for novel antiviral treatments.
- Phototherapy (PT), a light-based treatment, is explored for its potential against diverse diseases.
- Existing research demonstrates PT's efficacy in various viral infections, including respiratory and systemic viruses.
Purpose of the Study:
- To review the potential of phototherapy in combating viral infections.
- To summarize current advancements in photodynamic, photothermal, and photoacoustic antiviral therapies.
- To highlight PT's virucidal effects on systemic and emerging viruses.
Main Methods:
- Review of existing literature on phototherapy applications in virology.
- Analysis of photodynamic, photothermal, and photoacoustic mechanisms against viruses.
- Examination of PT's effectiveness against specific viral families and pandemic strains.
Main Results:
- Phototherapy demonstrates virucidal effects on systemic viruses like HIV and human herpesviruses (HHV8).
- PT shows potential for disinfection against noroviruses and pandemic viruses such as SARS-CoV-2.
- The review consolidates evidence for PT's broad-spectrum antiviral capabilities.
Conclusions:
- Phototherapy presents a viable, accessible, and rapidly deployable strategy for antiviral treatment.
- PT's mechanisms, including photodynamic, photothermal, and photoacoustic effects, offer versatile approaches to viral inactivation.
- Further research into PT modalities could lead to effective treatments for current and future viral pandemics.
Related Concept Videos
Retrovirus Life Cycles
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

